50 Years of Women in Cell Biology: Where have we been? Where are we going?


Journal

Molecular biology of the cell
ISSN: 1939-4586
Titre abrégé: Mol Biol Cell
Pays: United States
ID NLM: 9201390

Informations de publication

Date de publication:
01 12 2021
Historique:
entrez: 18 11 2021
pubmed: 19 11 2021
medline: 23 3 2022
Statut: ppublish

Résumé

It's been 50 years since Women in Cell Biology (WICB) was founded by junior women cell biologists who found themselves neither represented at the American Society for Cell Biology (ASCB) presentations nor receiving the information, mentoring, and sponsorship they needed to advance their careers. Since then, gender parity at ASCB has made significant strides: WICB has become a standing ASCB committee, women are regularly elected president of the ASCB, and half the symposia speakers are women. Many of WICB's pioneering initiatives for professional development, including career panels, workshops, awards for accomplishments in science and mentoring, and career mentoring roundtables, have been incorporated and adapted into broader "professional development" that benefits all members of ASCB. The time has passed when we can assume that all women benefit equally from progress. By strategically, thoughtfully, and honestly recognizing the challenges to women of the past and today, we may anticipate those new challenges that will arise in the

Identifiants

pubmed: 34793240
doi: 10.1091/mbc.E21-04-0186
pmc: PMC8694079
doi:

Types de publication

Historical Article Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Science. 2021 Apr 9;372(6538):133-135
pubmed: 33833113
Nature. 2020 Apr 17;:
pubmed: 32303729
JAMA Netw Open. 2020 Sep 1;3(9):e2018127
pubmed: 32986107
Nat Commun. 2021 Jun 22;12(1):3794
pubmed: 34158472
Mol Biol Cell. 2013 Jan;24(2):57-60
pubmed: 23307103
JAMA Netw Open. 2019 Apr 5;2(4):e192103
pubmed: 30977853
Proc Natl Acad Sci U S A. 2018 Jan 2;115(1):104-108
pubmed: 29255050
Science. 2020 Sep 18;369(6510):1440-1441
pubmed: 32943517
PeerJ. 2014 Oct 21;2:e627
pubmed: 25346879
Am J Public Health. 2012 Jul;102(7):1267-73
pubmed: 22594719
Nature. 2021 Mar;591(7851):501-502
pubmed: 33762773
PLoS One. 2016 Jul 28;11(7):e0160015
pubmed: 27467580
Science. 2011 Aug 19;333(6045):1015-9
pubmed: 21852498
Nat Commun. 2018 Apr 24;9(1):1358
pubmed: 29692409

Auteurs

Sandra K Masur (SK)

Icahn School of Medicine at Mount Sinai, New York, NY 10029.

Ursula Goodenough (U)

Washington University, St. Louis, MO 63130.

Caroline M Kane (CM)

University of California, Berkeley, Berkeley, CA 94720.

Elizabeth Marincola (E)

The African Academy of Sciences, Nairobi, Kenya 00502.

Maria Elena Zavala (ME)

California State University, Northridge, Northridge, CA 91330.

Julia Omotade (J)

The Association of American Medical Colleges, Washington, DC 20001.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH